Valuation : ViaDerma, Inc.

Market Cap 63.06L 54.34L 50.95L 46.51L 87.61L 60Cr 87.89L 6.04Cr 2.36Cr 30Cr 2.37Cr 2.32Cr 100.87Cr P/E 2015
10.7x
P/E 2016 -3.3x
Enterprise Value 66.02L 56.89L 53.34L 48.69L 91.73L 63Cr 92.02L 6.33Cr 2.47Cr 32Cr 2.48Cr 2.42Cr 105.62Cr EV / Sales 2015
1.5x
EV / Sales 2016 3.63x
Free-Float
99%
Yield 2015 *
-
Yield 2016 -
1 day-25.00%
1 week+200.00%
Current month+200.00%
1 month+29,900.00%
3 months-25.00%
6 months-25.00%
Current year+50.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0.01
3 years 0
Extreme 1.0E-6
0.02
5 years 0
Extreme 1.0E-6
0.03
10 years 0
Extreme 1.0E-6
0.08
Manager TitleAgeSince
Chief Executive Officer - 31/03/2014
Director TitleAgeSince
Chairman - 31/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
-25.00%+200.00%-70.00%-97.69% 1L
-0.78%-1.42%+2.96%+20.82% 5.05TCr
-6.00%-0.75%+447.48%+524.26% 4.46TCr
-0.24%+0.74%+37.18%+16.57% 4.31TCr
-1.55%-2.07%+19.83%+73.63% 4.17TCr
-0.31%-0.83%+19.47%+48.24% 3.32TCr
-1.79%-3.24%+26.32%+121.63% 1.68TCr
-0.58%-2.12% - - 1.63TCr
-0.88%-0.66%+11.63%+28.71% 1.46TCr
-1.66%-1.25%+78.49%+39.02% 1.39TCr
Average -3.88%-0.95%+63.71%+86.13% 2.75TCr
Weighted average by Cap. -1.70%-1.06%+96.28%+126.98%

Financials

2015 2016
Net sales 2L 2L 2L 1L 3L 1.83Cr 3L 18.38L 7L 92.52L 7L 7L 3.07Cr 3L 2L 2L 2L 4L 2.41Cr 4L 24.15L 9L 1.22Cr 9L 9L 4.03Cr
Net income 27.12T 23.37T 21.91T 20T 37.68T 25.92L 37.8T 3L 1L 13.08L 1L 99.61T 43.39L -1L -1L -98.41T -89.83T -2L -1.16Cr -2L -11.68L -5L -58.77L -5L -4L -1.95Cr
Net Debt 3L 2L 2L 2L 4L 2.75Cr 4L 27.63L 10.78L 1.39Cr 10.82L 10.59L 4.61Cr 3L 3L 2L 2L 4L 2.84Cr 4L 28.45L 11.1L 1.43Cr 11.14L 10.9L 4.75Cr
Logo ViaDerma, Inc.
ViaDerma, Inc. is a pharmaceutical company. The Company is engaged in the manufacture and sale of pharmaceutical related products in the United States of America. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The Company also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. Its products are based on a patent-pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Employees
75
Date Price Change Volume
26/26/26 $0.000100 -66.67% 26,700
25/26/25 $0.000300 +200.00% 7,510
  1. Stock Market
  2. Stocks
  3. VDRM Stock